Escalating interventional recanalization therapy in non-cirrhotic, non-malignant acute portal vein thrombosis.


Journal

European journal of gastroenterology & hepatology
ISSN: 1473-5687
Titre abrégé: Eur J Gastroenterol Hepatol
Pays: England
ID NLM: 9000874

Informations de publication

Date de publication:
Dec 2019
Historique:
pubmed: 5 10 2019
medline: 29 10 2020
entrez: 5 10 2019
Statut: ppublish

Résumé

To evaluate the effectiveness of interventional therapy in acute, non-malignant, non-cirrhotic portal vein thrombosis. We present a retrospective study of eight consecutive patients who presented with an acute non-malignant, non-cirrhotic portal vein thrombosis and were treated by mechanical recanalization using an escalating scheme including local aspiration, thrombolysis, rheolysis and the implantation of transjugular intrahepatic portosystemic shunt or other visceral stents. Recanalization rates applying the escalating scheme were good, with a success rate of 75%. However, major complications occurred in 50% of patients, mostly due to bleeding at the percutaneous access site, and minor complications in 12.5% of patients. Interventional therapy is effective in acute portal vein thrombosis, but should only be performed at specialized centers and based on an individual treatment decision.

Identifiants

pubmed: 31584464
doi: 10.1097/MEG.0000000000001559
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

1584-1591

Auteurs

Mirjam Gerwing (M)

Institute of Clinical Radiology, University Hospital Münster, Münster, Germany.

Christian Wilms (C)

Department of Gastroenterology and Hepatology, University Hospital Münster, Münster, Germany.

Hauke Heinzow (H)

Department of Gastroenterology and Hepatology, University Hospital Münster, Münster, Germany.

Peter B Sporns (PB)

Institute of Clinical Radiology, University Hospital Münster, Münster, Germany.

Walter Heindel (W)

Institute of Clinical Radiology, University Hospital Münster, Münster, Germany.

Hartmut Schmidt (H)

Department of Gastroenterology and Hepatology, University Hospital Münster, Münster, Germany.

Moritz Wildgruber (M)

Institute of Clinical Radiology, University Hospital Münster, Münster, Germany.

Michael Köhler (M)

Institute of Clinical Radiology, University Hospital Münster, Münster, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH